• Something wrong with this record ?

Physiology-based toxicokinetic modelling in the frame of the European Human Biomonitoring Initiative

DA. Sarigiannis, S. Karakitsios, E. Dominguez-Romero, K. Papadaki, C. Brochot, V. Kumar, M. Schuhmacher, M. Sy, H. Mielke, M. Greiner, M. Mengelers, M. Scheringer,

. 2019 ; 172 (-) : 216-230. [pub] 20190129

Language English Country Netherlands

Document type Journal Article, Research Support, Non-U.S. Gov't, Review

Given the opportunities provided by internal dosimetry modelling in the interpretation of human biomonitoring (HBM) data, the assessment of the links between exposure to chemicals and observed HBM data can be effectively supported by PBTK modelling. This paper gives a comprehensive review of available human PBTK models for compounds selected as a priority by the European Human Biomonitoring Initiative (HBM4EU). We highlight their advantages and deficiencies and suggest steps for advanced internal dose modelling. The review of the available PBTK models highlighted the conceptual differences between older models compared to the ones developed recently, reflecting commensurate differences in research questions. Due to the lack of coordinated strategies for deriving useful biomonitoring data for toxicokinetic properties, significant problems in model parameterisation still remain; these are further increased by the lack of human toxicokinetic data due to ethics issues. Finally, questions arise as well as to the extent they are really representative of interindividual variability. QSARs for toxicokinetic properties is a complementary approach for PBTK model parameterisation, especially for data poor chemicals. This approach could be expanded to model chemico-biological interactions such as intestinal absorption and renal clearance; this could serve the development of more complex generic PBTK models that could be applied to newly derived chemicals. Another gap identified is the framework for mixture interaction terms among compounds that could eventually interact in metabolism. From the review it was concluded that efforts should be shifted toward the development of generic multi-compartmental and multi-route models, supported by targeted biomonitoring coupled with parameterisation by both QSAR approach and experimental (in-vivo and in-vitro) data for newly developed and data poor compounds.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20006559
003      
CZ-PrNML
005      
20200520155013.0
007      
ta
008      
200511s2019 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.envres.2019.01.045 $2 doi
035    __
$a (PubMed)30818231
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Sarigiannis, Dimosthenis A $u Aristotle University of Thessaloniki, Department of Chemical Engineering, Environmental Engineering Laboratory, University Campus, Thessaloniki 54124, Greece; HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece. Electronic address: denis@eng.auth.gr.
245    10
$a Physiology-based toxicokinetic modelling in the frame of the European Human Biomonitoring Initiative / $c DA. Sarigiannis, S. Karakitsios, E. Dominguez-Romero, K. Papadaki, C. Brochot, V. Kumar, M. Schuhmacher, M. Sy, H. Mielke, M. Greiner, M. Mengelers, M. Scheringer,
520    9_
$a Given the opportunities provided by internal dosimetry modelling in the interpretation of human biomonitoring (HBM) data, the assessment of the links between exposure to chemicals and observed HBM data can be effectively supported by PBTK modelling. This paper gives a comprehensive review of available human PBTK models for compounds selected as a priority by the European Human Biomonitoring Initiative (HBM4EU). We highlight their advantages and deficiencies and suggest steps for advanced internal dose modelling. The review of the available PBTK models highlighted the conceptual differences between older models compared to the ones developed recently, reflecting commensurate differences in research questions. Due to the lack of coordinated strategies for deriving useful biomonitoring data for toxicokinetic properties, significant problems in model parameterisation still remain; these are further increased by the lack of human toxicokinetic data due to ethics issues. Finally, questions arise as well as to the extent they are really representative of interindividual variability. QSARs for toxicokinetic properties is a complementary approach for PBTK model parameterisation, especially for data poor chemicals. This approach could be expanded to model chemico-biological interactions such as intestinal absorption and renal clearance; this could serve the development of more complex generic PBTK models that could be applied to newly derived chemicals. Another gap identified is the framework for mixture interaction terms among compounds that could eventually interact in metabolism. From the review it was concluded that efforts should be shifted toward the development of generic multi-compartmental and multi-route models, supported by targeted biomonitoring coupled with parameterisation by both QSAR approach and experimental (in-vivo and in-vitro) data for newly developed and data poor compounds.
650    12
$a biologický monitoring $7 D000079687
650    _2
$a lidé $7 D006801
650    12
$a biologické modely $7 D008954
650    _2
$a kvantitativní vztahy mezi strukturou a aktivitou $7 D021281
650    12
$a toxikokinetika $7 D066007
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Karakitsios, Spyros $u Aristotle University of Thessaloniki, Department of Chemical Engineering, Environmental Engineering Laboratory, University Campus, Thessaloniki 54124, Greece; HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece.
700    1_
$a Dominguez-Romero, Elena $u RECETOX, Masaryk University, Brno, Czech Republic.
700    1_
$a Papadaki, Krystalia $u Aristotle University of Thessaloniki, Department of Chemical Engineering, Environmental Engineering Laboratory, University Campus, Thessaloniki 54124, Greece.
700    1_
$a Brochot, Celine $u INERIS, France.
700    1_
$a Kumar, Vikas $u IISPV, Tarragona, Spain.
700    1_
$a Schuhmacher, Marta $u IISPV, Tarragona, Spain.
700    1_
$a Sy, Moustapha $u BfR, Berlin, Germany.
700    1_
$a Mielke, Hans $u BfR, Berlin, Germany.
700    1_
$a Greiner, Mathias $u BfR, Berlin, Germany.
700    1_
$a Mengelers, Marcel $u RIVM, Utrecht, the Netherlands.
700    1_
$a Scheringer, Martin $u RECETOX, Masaryk University, Brno, Czech Republic.
773    0_
$w MED00001557 $t Environmental research $x 1096-0953 $g Roč. 172, č. - (2019), s. 216-230
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30818231 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200520155012 $b ABA008
999    __
$a ok $b bmc $g 1525417 $s 1096615
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 172 $c - $d 216-230 $e 20190129 $i 1096-0953 $m Environmental research. Section A $n Environ Res $x MED00001557
LZP    __
$a Pubmed-20200511

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...